Hepatitis A vaccine
Hepatitis A vaccine is a biological therapy with 28 clinical trials. Currently 5 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
7
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
16 of 18 finished
11.1%
2 ended early
5
trials recruiting
28
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
Clinical Trials (28)
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa
Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study
A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
PCV13 + Hepatitis a Vaccine for Adults
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.
A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19
Phase 1 Study of MGD010 in Healthy Subjects
A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine
Comparative Immunogenicity Study of Two Hepatitis A Vaccines
A Controlled Study to Evaluate the Safety and Immunogenicity of StreptAnova™ in Healthy Adults
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 28